Zacks Investment Research
10 Nov 2026, 23:45 UTC · 17h ago
Medtronic (MDT) Dips More Than Broader Market: What You Should Know
Impact · against what's priced in
The article provides no new catalyst for Medtronic, as the projected earnings and revenue figures align almost exactly with current market expectations. The stock's recent outperformance and the upcoming November 24 earnings date are already integrated into the current valuation.
- MDT+0.00
Already priced in
- The price assumes
Fiscal 2027 organic revenue growth of 7.25%–7.75% and non-GAAP EPS of $5.94–$6.00
The projected full-year earnings of $5.98 per share and revenue growth of 7.34% are entirely consistent with the growth and EPS targets the price already assumes.
What MDT's price assumes · Sep 9
Top 1 mover · tap to explore
